Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Selective cyclooxygenase inhibitors prevent the growth of Chlamydia pneumoniae in HL cells.

Yan Y, Silvennoinen-Kassinen S, Törmäkangas L, Leinonen M, Saikku P.

Int J Antimicrob Agents. 2008 Jul;32(1):78-83. doi: 10.1016/j.ijantimicag.2008.02.021. Epub 2008 Jun 4.

PMID:
18524544
2.

The inhibitory effect of disodium cromoglycate on the growth of Chlamydophila (Chlamydia) pneumoniae in vitro.

Yamazaki T, Yamaguchi T, Sasaki N, Inoue M, Sato K, Kishimoto T.

Biol Pharm Bull. 2006 Apr;29(4):799-800.

3.

Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment.

Gieffers J, Füllgraf H, Jahn J, Klinger M, Dalhoff K, Katus HA, Solbach W, Maass M.

Circulation. 2001 Jan 23;103(3):351-6.

4.

Chlamydia pneumoniae resists antibiotics in lymphocytes.

Yamaguchi H, Friedman H, Yamamoto M, Yasuda K, Yamamoto Y.

Antimicrob Agents Chemother. 2003 Jun;47(6):1972-5.

5.

Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures.

Alvesalo J, Vuorela H, Tammela P, Leinonen M, Saikku P, Vuorela P.

Biochem Pharmacol. 2006 Mar 14;71(6):735-41. Epub 2006 Jan 18.

PMID:
16414027
6.

Serotonin and melatonin, neurohormones for homeostasis, as novel inhibitors of infections by the intracellular parasite chlamydia.

Rahman MA, Azuma Y, Fukunaga H, Murakami T, Sugi K, Fukushi H, Miura K, Suzuki H, Shirai M.

J Antimicrob Chemother. 2005 Nov;56(5):861-8. Epub 2005 Sep 19.

PMID:
16172105
7.

Chlamydia pneumoniae growth inhibition in human monocytic THP-1 cells and human epithelial HEp-2 cells by a novel phenoxazine derivative.

Uruma T, Yamaguchi H, Fukuda M, Kawakami H, Goto H, Kishimoto T, Yamamoto Y, Tomoda A, Kamiya S.

J Med Microbiol. 2005 Dec;54(Pt 12):1143-9.

PMID:
16278427
8.
9.

Raloxifene promotes prostacyclin release in human endothelial cells through a mechanism that involves cyclooxygenase-1 and -2.

Oviedo PJ, Hermenegildo C, Tarín JJ, Cano A.

Fertil Steril. 2005 Jun;83(6):1822-9.

PMID:
15950656
10.

Azithromycin inhibits interleukin-6 but not fibrinogen production in hepatocytes infected with cytomegalovirus and chlamydia pneumoniae.

Bouwman JJ, Visseren FL, Bouter PK, Diepersloot RJ.

J Lab Clin Med. 2004 Jul;144(1):18-26.

PMID:
15252403
11.

In vitro inhibitory effects of tea polyphenols on the proliferation of Chlamydia trachomatis and Chlamydia pneumoniae.

Yamazaki T, Inoue M, Sasaki N, Hagiwara T, Kishimoto T, Shiga S, Ogawa M, Hara Y, Matsumoto T.

Jpn J Infect Dis. 2003 Aug;56(4):143-5.

12.

Rapamycin can inhibit the development of Chlamydia pneumoniae, which might partly contribute to the prevention of in-stent restenosis.

Yan Y, Silvennoinen-Kassinen S, Leinonen M, Saikku P.

Cardiovasc Drugs Ther. 2010 Jun;24(3):189-95. doi: 10.1007/s10557-010-6238-8.

PMID:
20532971
13.

Effect of levofloxacin on the viability of intracellular Chlamydia pneumoniae and modulation of proinflammatory cytokine production by human monocytes.

Baltch AL, Smith RP, Ritz WJ, Carpenter AN, Bopp LH, Michelsen PB, Carlyn CJ, Hibbs JR.

Diagn Microbiol Infect Dis. 2004 Nov;50(3):205-12.

PMID:
15541607
14.

Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone).

Yamaguchi H, Kamiya S, Uruma T, Osaki T, Taguchi H, Hanawa T, Fukuda M, Kawakami H, Goto H, Friedman H, Yamamoto Y.

Antimicrob Agents Chemother. 2008 Jun;52(6):1991-8. doi: 10.1128/AAC.01416-07. Epub 2008 Mar 17.

15.

Effect of nitric oxide on the growth of Chlamydophila pneumoniae.

Carratelli CR, Rizzo A, Paolillo R, Catania MR, Catalanotti P, Rossano F.

Can J Microbiol. 2005 Nov;51(11):941-7.

PMID:
16333333
16.

A Chlamydia pneumoniae infection model using established human lymphocyte cell lines.

Yamaguchi H, Haranaga S, Friedman H, Moor JA, Muffly KE, Yamamoto Y.

FEMS Microbiol Lett. 2002 Nov 5;216(2):229-34.

17.

Effects of COX-2 inhibitors on ROS produced by Chlamydia pneumoniae-primed human promonocytic cells (THP-1).

Mouithys-Mickalad A, Deby-Dupont G, Dogne JM, de Leval X, Kohnen S, Navet R, Sluse F, Hoebeke M, Pirotte B, Lamy M.

Biochem Biophys Res Commun. 2004 Dec 24;325(4):1122-30.

PMID:
15555544
18.

In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model.

Kutlin A, Roblin PM, Hammerschlag MR.

Antimicrob Agents Chemother. 1999 Sep;43(9):2268-72.

19.

Effects of nonselective and selective cyclooxygenase inhibitors on small intestinal motility in the horse.

Menozzi A, Pozzoli C, Poli E, Dacasto M, Giantin M, Lopparelli RM, Passeri B, Zullian C, Gobbetti T, Bertini S.

Res Vet Sci. 2009 Feb;86(1):129-35. doi: 10.1016/j.rvsc.2008.04.006. Epub 2008 Jun 18.

PMID:
18565556
20.

Tobacco smoke induces a persistent, but recoverable state in Chlamydia pneumoniae infection of human endothelial cells.

Wiedeman JA, Kaul R, Heuer LS, Thao NN, Pinkerton KE, Wenman WM.

Microb Pathog. 2005 Nov-Dec;39(5-6):197-204. Epub 2005 Nov 4.

PMID:
16271847

Supplemental Content

Support Center